|Datasheet||Specific References||Reviews||Related Products||Protocols|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Rat JAM2 ORF mammalian expression plasmid, C-GFPSpark tag||RG80376-ACG|
|Rat JAM2 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||RG80376-ACR|
|Rat JAM2 ORF mammalian expression plasmid, C-Flag tag||RG80376-CF|
|Rat JAM2 ORF mammalian expression plasmid, C-His tag||RG80376-CH|
|Rat JAM2 ORF mammalian expression plasmid, C-Myc tag||RG80376-CM|
|Rat JAM2 ORF mammalian expression plasmid, C-HA tag||RG80376-CY|
|Rat JAM2 ORF mammalian expression plasmid, N-Flag tag||RG80376-NF|
|Rat JAM2 ORF mammalian expression plasmid, N-His tag||RG80376-NH|
|Rat JAM2 ORF mammalian expression plasmid, N-Myc tag||RG80376-NM|
|Rat JAM2 ORF mammalian expression plasmid, N-HA tag||RG80376-NY|
|Rat JAM2 natural ORF mammalian expression plasmid||RG80376-UT|
|Learn more about expression Vectors|
Junctional adhesion molecule B (JAM-B), also known as Junctional adhesion molecule 2 (JAM2), Vascular endothelial junction-associated molecule (VE-JAM), and CD322, is a single-pass type I membrane protein which belongs to the immunoglobulin superfamily. It is prominently expressed on high endothelial venules. expression to be restricted to the high endothelial venule of tonsil and lymph nodes. The localization to the endothelium of arterioles in and around inflammatory and tumor foci. JAM-B can function as an adhesive ligand for the T cell line J45 and can interact with GM-CSF/IL-4-derived peripheral blood dendritic cells, circulating CD56(+) NK cells, circulating CD56(+)CD3(+) NK/T cells, and circulating CD56(+)CD3(+)CD8(+) cytolytic T cells. JAM-2 is expressed on high endothelial venules (HEVs) in human tonsil and on a subset of human leukocytes, suggesting that JAM-2 plays a central role in the regulation of transendothelial migration. It binds to very late activation antigen (VLA)-4, a leucocyte integrin that contributes to rolling and firm adhesion of lymphocytes to endothelial cells through binding to vascular cell adhesion molecule (VCAM)-1. JAM-B appears to contribute to leucocyte extravasation by facilitating not only transmigration but also rolling and adhesion. JAM-B acts as an adhesive ligand for interacting with a variety of immune cell types and may play a role in lymphocyte homing to secondary lymphoid organs.